These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35568442)

  • 1. Drugs Recommended in Adult Rheumatic Diseases, But Considered for Off-Label Use in Argentina.
    Villalobos F; Matellan C; Sequeira G; Kerzberg E
    Reumatol Clin (Engl Ed); 2022 May; 18(5):286-292. PubMed ID: 35568442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs Recommended in Adult Rheumatic Diseases, But Considered for Off-Label Use in Argentina.
    Villalobos F; Matellan C; Sequeira G; Kerzberg E
    Reumatol Clin (Engl Ed); 2021 Feb; ():. PubMed ID: 33640322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Rheumatol; 2017 Aug; 69(8):1538-1551. PubMed ID: 28620948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative assessment of off-label and unlicensed drug prescription in neonatal intensive care: FDA versus Brazilian guidelines].
    Costa HTML; Florencio AP; Bezerra PKDV; Cavalcanti JEC; Costa TX; Fernandes FEM; Martins RR
    An Pediatr (Engl Ed); 2021 Mar; 94(3):153-160. PubMed ID: 33514478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    J Arthroplasty; 2017 Sep; 32(9):2628-2638. PubMed ID: 28629905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese expert consensus on off-label use of Tocilizumab in rheumatic diseases].
    Committee of Chinese Primary Health Care Foundation for Rheumatologists and Immunologists
    Zhonghua Yi Xue Za Zhi; 2024 Jul; 104(25):2308-2322. PubMed ID: 38951103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chinese expert-based consensus for methotrexate in rheumatic diseases].
    Chinese Association of Rheumatology and Immunology Physicians
    Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):719-722. PubMed ID: 30293331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical Pearls About Current Rheumatic Medications.
    Ward IM; Knott A
    Prim Care; 2018 Jun; 45(2):193-212. PubMed ID: 29759120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].
    Briem S; Lorenz HM
    Z Rheumatol; 2011 Feb; 70(2):123-8. PubMed ID: 21267732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portuguese recommendations for the use of ultrasound in rheumatology.
    Polido-Pereira J; Serra S; Teixeira F; Ponte C; Cerqueira M; Cruz M; Araújo F; Barros R; Costa T; Santos-Faria D; Lopes C; Madruga-Dias J; Oliveira M; Teixeira R; Vilar A; Falcão S; Saraiva F; Figueiredo G
    Acta Reumatol Port; 2019; 44(1):7-28. PubMed ID: 31249273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.
    Goodman SM; Springer B; Guyatt G; Abdel MP; Dasa V; George M; Gewurz-Singer O; Giles JT; Johnson B; Lee S; Mandl LA; Mont MA; Sculco P; Sporer S; Stryker L; Turgunbaev M; Brause B; Chen AF; Gililland J; Goodman M; Hurley-Rosenblatt A; Kirou K; Losina E; MacKenzie R; Michaud K; Mikuls T; Russell L; Sah A; Miller AS; Singh JA; Yates A
    Arthritis Care Res (Hoboken); 2017 Aug; 69(8):1111-1124. PubMed ID: 28620917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [S3 guidelines on treatment of polymyalgia rheumatica : Evidence-based guidelines of the German Society of Rheumatology (DGRh), the Austrian Society of Rheumatology and Rehabilitation (ÖGR) and the Swiss Society of Rheumatology (SGT) and participating medical scientific specialist societies and other organizations].
    Buttgereit F; ; Brabant T; ; Dinges H; ; Hiemer I; ; Kaplani M; ; Kiltz U; Kyburz D; ; Reißhauer A; ; Schneider M; Weseloh C; Dejaco C;
    Z Rheumatol; 2018 Jun; 77(5):429-441. PubMed ID: 29845555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for the use of parenteral methotrexate in rheumatic diseases.
    Tornero Molina J; Calvo Alen J; Ballina J; Belmonte MÁ; Blanco FJ; Caracuel MÁ; Carbonell J; Corominas H; Chamizo E; Hidalgo C; Ivorra JR; Marenco JL; Moreno Muelas JV; Muñoz-Fernández S; Nolla JM; Pérez T; Sanmarti R; Trenor P; Urrego C; Vidal J; Rosas Gomez de Salazar J
    Reumatol Clin (Engl Ed); 2018; 14(3):142-149. PubMed ID: 28082032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label use of rituximab in systemic rheumatic diseases: case series and review.
    Araújo F; Silva I; Sepriano A; Nero P; Branco JC
    Acta Reumatol Port; 2013; 38(4):290-4. PubMed ID: 24435034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2014 update of the Consensus Statement of the Spanish Society of Rheumatology on the use of biological therapies in rheumatoid arthritis.
    Sanmartí R; García-Rodríguez S; Álvaro-Gracia JM; Andreu JL; Balsa A; Cáliz R; Fernández-Nebro A; Ferraz-Amaro I; Gómez-Reino JJ; González-Álvaro I; Martín-Mola E; Martínez-Taboada VM; Ortiz AM; Tornero J; Marsal S; Moreno-Muelas JV
    Reumatol Clin; 2015; 11(5):279-94. PubMed ID: 26051464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for the use of biologic therapy from the Italian Society for Rheumatology: off-label use.
    Todoerti M; Pipitone N; Matucci-Cerinic M; Montecucco C; Caporali R;
    Clin Exp Rheumatol; 2011; 29(3 Suppl 66):S42-62. PubMed ID: 21906426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology.
    Mok CC; Tam LS; Chan TH; Lee GK; Li EK;
    Clin Rheumatol; 2011 Mar; 30(3):303-12. PubMed ID: 21046421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Established medications : new areas of application].
    Kötter I; Henes JC
    Z Rheumatol; 2013 Nov; 72(9):853-66. PubMed ID: 24193188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pharmacological strategies in rheumatic diseases.
    Schiotis RE; Buzoianu AD; Mureșanu DF; Suciu S
    J Med Life; 2016; 9(3):227-234. PubMed ID: 27974925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis on off-label use of drugs in pediatric guidelines and consensus published by Chinese authors].
    Meng M; Wang P; Lan H; Lei WJ; Shen Q; Zhou Q; Su RF; Lyu M; Yang B; Luo XF; Lei RB; Hou TC; Li Q; Chen Y
    Zhonghua Er Ke Za Zhi; 2022 Mar; 60(3):215-220. PubMed ID: 35240741
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.